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ABSTRACT
Negative affect (NA) is a known precipitant of cravings, and each are robust

predictors of lapses, making this pathway an excellent target for lapse prevention in opioid

treatment. As emotion dyregulation arises from unmitigated NA, deficits in emotion

regulation (ER) contribute to cravings in part by worsening distress, although the form
these deficits take remains unclear. Coping motives are relevant in the context of NA and
show robust associations with ER difficulties. Further, coping motives have demonstrated
a similar role in exacerbating the effect NA has on cravings. This study aimed to explore

the conditional indirect effects of ER deficits (in the form high reliance on maladaptive

strategies and insufficient use of adaptive strategies) on NA and craving via the conditional
effects of coping motives in opioid use in a piecemeal approach.

Treatment seeking opioid users less than 90 days clean (N=57) completed
dispositional measures of using motives and ER repertoires followed by a 7-day

ecological momentary assessment protocol indexing ratings of NA and craving across

each day. General and mixed-effects linear models were fit to test hypothesized effects.
Results indicate coping, enhancement, and pain, but not social motives predict
maladaptive ER and no using motives predict adaptive ER. Coping motives and within-

person fluctuations in NA interactively predict craving, with simple effects suggesting
high dispositional coping motives exacerbate the effect of NA on craving and individual

differences explain the variability in this effect. Conditional indirect effect of ER deficits

iii

via coping motives could not be tested due to insufficient statistical power, but the total
effect of maladaptive repertoires and within-person fluctuations in NA interactively

predict craving at a trend level. Simple effects suggest high maladaptive repertoires

exacerbate the effect of NA on craving and individual differences explain the variability
in this effect. Adaptive ER interactions were not interpretable. These finding suggest
understanding using motives and reliance on maladaptive ER may help identify increased
lapse risk in clinical settings.
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CHAPTER I

INTRODUCTION

On October 27th, 2017, the opioid crisis was declared a nationwide Public Health
Emergency. This declaration, motivated by the opioid overdoes-related deaths that doubled

2012 to 47,600 in 2017 (National Institute on Drug Abuse, 2018), reflects an epidemic

level of functionally-impairing opioid use that is estimated to affect over 2.5 million
Americans annually as of 2019 (National Institute on Drug Abuse, 2019). Enshrined in the

DSM-5 under the auspices of Opioid Use Disorder, such problematic patterns of use lead
to clinically significant impairment or distress, and are associated with uncontrollable
cravings and inability to reduce opioid use despite harmful consequences (Diagnostic and

Statistical Manual of Mental Disorders: DSM-5, 2013), and are tied to a $78.5 billion

annual burden in the US taking the forms of treatment, criminal justice, and healthcare
expenses, as well as lost productivity (Florence et al., 2016). Further, despite improvements

in behavioral healthcare over the past few decades (Kilbourne et al., 2018) Opioid Use

Disorder treatment efficacy remains relatively low. In particular, around 50% of treatment
seekers terminate care prematurely (Scott et al., 2005; Salamina et al., 2010), which for
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many presages a return to pre-treatment opioid use levels (Zhang, Friedmann, & Gerstein,
2003).

Chemical abstinence during treatment is a key predictor of treatment retention
(Sullivan, Rothenberg et al, 2006), with sobriety lapses, or a short return to substance use,

prognosticating premature treatment withdrawal (Panlilio et al., 2019). Therefore,

elucidating process and mechanisms that may predict sobriety lapses may be a key step to

increasing treatment retention and addressing this important public health problem.

1.1 Craving in Opioid Treatment
Craving is an integral component of Opioid Use Disorder (OUD). Enshrined as a
qualifying criterion for OUD in the DSM-V (American Psychiatric Association, 2013)
and the ICD-10 (World Health Organization, 2016), the prevailing definition among
experts describes craving as a subjective experience of wanting to use a drug (Tiffany &

Wray, 2011). However, craving has been conceptualized in various ways. For instance,
some neuroscience informed models posit craving as perseverative, anxiogenic cognitive

process that is temporarily alleviated by substance use (Anton, 2000; Rosenberg, 2009),
while others employ approach-avoidance paradigms to characterize conflicting desires to
use but avoid repercussions of using said substance (Rosenberg, 2009). Other
multidimensional models suggest the need to consider craving’s intensity, duration, and

frequency (Flannery et al, 1999; Rosenberg, 2009), and incorporate motivational states in
the construct’s formulation (Rosenberg, 2009).

In this study, I use the prevailing definition of craving as it was deemed a valid
clinical criterion by the National Institute on Drug Abuse (Tiffany & Wray, 2011).

Indeed, studies employing Ecological Momentary Assessment (EMA) paradigms show
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robust links between craving and sobriety lapses in outpatient samples (Fatseas et al.,

2018; McHugh et al., 2014; Moore et al., 2014; Panlilio et al., 2019) and treatment
dropout (Panlilio et al., 2019). For instance, elevated cravings were linked to a 14-fold

increase in risk for a sobriety lapse across subsequent EMAs in a mixed substance use
treatment sample (Moore et al., 2014), and with a 17% increase in risk for opioid use per

unit of craving in the Prescription Opioid Addiction Treatment Study (McHugh et al.,

2014). Importantly, the relationship between cravings and sobriety lapses remain when
psychiatric comorbidities are statistically controlled (Fatseas et al., 2018). As sobriety
lapses are a robust prognosticator of early treatment termination (Panlilio et al., 2019)

and a substance use relapse (Raj et al., 2000), elucidating mechanisms for increased
craving intensity may improve treatment retention and the likelihood of sustaining

abstinence and the recovery process.

1.2 Craving and Negative Affect
Substance-related cravings have strong affective ties (Tiffany, 2010), and are
believed by some to have emotional substrates (Baker, Morse, & Sherman, 1987;
Franken, 2003). For example, insofar as emotions reflect motivational states (Frijda,

1986), craving, or the desire for a substance, reflects an affective approach action
tendency to seek said substance (Baker et al., 2004). Though linked with both hedonic

and dysphoric states (Baker et al., 2004), a large body of work points to emotional

distress, spanning fear, anxiety, hostility, scorn, loneliness, and sadness (Negative Affect,
NA) (Watson, Clark, & Tellegen, 1988) as a precipitant of opioid misuse (Martel et al.,

2014) and relapse following drug abstinence (Marlatt, 2005). For instance, negative affect
predicted increased craving levels, that, in turn, were linked to opioid misuse tendencies
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within a sample of chronic pain patients (Martel et al., 2014, but see Wasan et al, 2012

for negative findings). In a similar vein, Bradley and colleagues showed that negative
mood states were one of the greatest risk factors for lapses, in addition to cognitions and

environmental triggers, among recently discharged inpatient-heroin users (Bradley et al.,

1989), and was reported as an antecedent to recent use among those seeking treatment
(Schonfeld et al., 1989). In consort, results from the experimental literature show robust
associations between induced negative mood states and craving for tobacco, alcohol, and

cocaine (Bresin et al., 2018; Conklin & Perkins, 2005; Maude-Griffin & Tiffany, 1996;
Perkins & Grobe, 1992; Tiffany & Drobes, 1990; Sinha et al., 2000; Sinha et al., 2006),
as well as opioids (Childress et al., 1994). Namely, hypnotically induced dysphoria,
anxiety, and anger triggered elevated cravings for opioids among detoxified opioid-abuse

patients (Childress et al., 1994). Along similar lines, experimental designs employing

noxious stimuli (e.g., shock) showed heroin-seeking behavior reinstatement in the
presence of heroin cues within animal studies (e.g., Shaham, Rajabi, & Stewart, 1996),

and among humans when aversive interpersonal conditions were employed (Back et al.,

2015; Saraiya et al., 2021). As with animal studies, participants with Opioid Use Disorder
reported increased cravings for opioids following aversive interpersonal conditions (Trier
Social Stress Test) within an opioid-cue paradigm that significantly predicted a reduced

time-course to opioid use (Saraiya et al., 2021; Back et al., 2015).

Correlational survey designs that test relationships naturalistically as they unfold
in daily life through experience sampling methodologies (Ecological Momentary

Assessment, EMA) also support the distress-craving association. One EMA study

examined affect and craving in a prescription opioid-dependent sample, in which main
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effects between negative affect and craving were significant at both the person- and day
level. This means participants experiencing high negative affect throughout the study

reported higher craving overall relative to peers with low negative affect (person-level),

as well as further increase in their cravings on days where their distress exceeded their
usual levels across the twelve-day monitoring period (day-level) (Huhn et al., 2016).

These findings were independently replicated across an eight-to-ten-day monitoring
period within an inpatient-treatment sample (Jenkins et al., 2021). Likewise, within an

opioid-dependent sample, negative mood (distress) and craving preceded abstinence
lapses (Preston et al, 2018).

Given its ties to sobriety lapses, the negative affect-craving relationship has

implications for treatment retention and outcomes. Indeed, some postulate that substance
use is for some a means to alleviate negative affect (Khantzian, 1985 & 1997; Conger,
1956; Sher & Levenson, 1982; Marlatt, 1987; Sher, 1987), thereby suggesting that

cravings serve as a maladaptive coping cue that is maintained through negative

reinforcement (Koob & Le Moal, 2008). The following sections explore the role of
Emotion Regulation (ER), a construct closely tied to coping, in connection between

negative affect and coping.

1.3 Emotion Regulation & Craving in Opioid Use
Emotion regulation (ER) refers to automatic and volitional processes that

modulate the temporal course, intensity, and phenomenology of emotional experience
across both positive and negative valences (Thompson, 1994; Gross, 2001). ER responses

span the cognitive, behavioral, and interpersonal domains (Wenzlaff & Luxtion, 2003;
Chapman, Dixon-Gordon, & Walters, 2011) and are considered maladaptive when their
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intent serves short-term at the cost of long-term regulatory goals. Conversely, adaptive

responses are those that serve short- and long-term goals, as appropriate to context
(Kovacs, Rottenberg, & George, 2009). As example, some adaptive ER strategies include

exercise (behavioral), humor (cognitive), and talking to friends (interpersonal) and
maladaptive strategies include drug use (behavioral), rumination (cognitive), and

isolation (interpersonal) (Kovacs et al., 2009).

ER deficits take the form of an excessive reliance on maladaptive strategies and
the infrequent or ineffective deployment of adaptive responses. ER deficits are a

transdiagnostic risk factor, involved in the development and maintenance of many
psychiatric conditions, including depression, borderline personality disorder, eating
disorders, somatoform disorders, and substance use disorders (SUDs) (Aldao, Nolen-

Hoeksema, & Schweizer, 2010; Gross & Munoz, 1995; Berking et al., 2014; Carpenter &
Trull, 2013; Glenn & Klonsky, 2009; Svaldi et al., 2012; Prefit et al., 2019; Waller &

Scheidt, 2006; Kober, 2014).
Concerning SUDs, ER deficits may be involved in at least two ways: 1) substance
use is a maladaptive ER strategy (Kovacs et al., 2009) and 2) ER deficits maintain and

exacerbate distress, thereby increasing substance-related cravings (Cicchetti et al., 1995).

As a maladaptive ER response, acute drag intoxication is an effective means to downregulate negative affect and up-regulate positive affect, as well as decrease cravings

(Kober, 2014), which is in line with Khantzian’s Self-Medication Hypothesis (1985).
Irrespective of the regulatory motive (enhance positive affect or cope with negative affect),

substance use is considered a maladaptive ER strategy as the behavior often compounds
problems long term, leading to negative substance-related outcomes (Peraza et al., 2019).
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Concerning their role as a substance use risk-factor, emotion regulation deficits are
linked to intense, enduring negative emotional states that lead to disruptive or self

destructive behavioral responses (emotion dysregulation, ED). ED is more prevalent

among those with substance use problems than in the general population (Kober, 2014),
and is positively associated with substance use frequency and severity (Garke et al., 2021),
and an increased risk of opioid misuse among chronic pain patients (Lutz, Gross, &

Vargovich, 2019). In a similar vein, ER deficits from which ED arises predict a rapid return

to regular substance use following treatment (Hyman et al., 2009; Ottonello et al., 2019).
Following a 28-day rehabilitation program, those who evidence an early relapse exhibited
more ER difficulties (specifically with “emotional clarity”) relative to those still abstinent

one month after discharge (Ottonello et al., 2019).

Craving is a likely pathway by which ER deficits and ED confer risk for
substance use (Evenden, 1999; Fox, Bergquist, Hong & Sinha, 2007; Fox, Hong, Sinha,

2008). Opioid-dependent patients report deploying adaptive ER responses less frequently
than healthy controls (Hyman et al., 2009), with similar deficits linked to emotional

distress and craving among chronic pain patients at risk for misusing prescription opioids
(Garland et al., 2018). On the other hand, deploying such maladaptive ER responses as
thought suppression has been associated with opioid cravings (Garland et al., 2016).

Similar negative and positive associations between adaptive and maladaptive ER
responses and cravings have been shown by others within mixed substance-dependent

samples (Basharpoor, 2014; Ottonello et al., 2019), among those with problematic
marijuana use (Asiaban, Imani, & Shokri, 2020), alcohol problems (Khosravani et al.,

2019), and heroin-dependence (Ghorbani et al., 2019), respectively.
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As ED arises from unmitigated negative affect, ER deficits likely contribute to
opioid cravings in part by worsening distress (Evenden, 1999; Fox, Bergquist, Hong &

Sinha, 2007; Fox, Hong, Sinha, 2008). This implies that ER deficits moderate the
association between negative affect and opioid craving. Indirect evidence for the

possibility arises from studies showing a reduced association between negative affect and
craving among cigarette smokers as a function of ER (Yuan et al., 2018), and the

reduction in craving as a function of improved ER among a mixed-substance-dependent

sample (Choopan et al., 2016) and those with opioid dependence (Garland & Howard,

2013). In the context of literature that links ER deficits with negative affect (Cicchetti et
al., 1995), the therapeutic benefits of ER training on substance-related cravings indirectly

support ER in a buffering role between negative affect and craving. However, it remains
unclear whether the link between negative affect and craving is strengthened by sparse

adaptive ER response repertoires, over-reliance on maladaptive responses, or both.

1.4 Motives for Opioid Use & Emotion Regulation
Although opioid use problems arise from the habitual use of the drug, the
motivations for such use are varied, with some endorsing pain management, socialrelated, positive affect enhancement, negative affect reduction as reasons for their

problematic opioid use (Jones et al., 2014). The construct of substance use motives

originated in the work of Cox and Klinger (1988). They created a motivational model for
alcohol use, which posits that people decide to drink or not drink on the basis of whether
the positive affective consequence they expect to achieve by drinking outweighs the

consequences of not drinking. This hypothesis combines literatures on emotion and
motivational theory to explain alcohol use. It is the bedrock from which motivational
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counseling for alcoholism is built on. Also emanating from Cox and Klinger’s Incentive
Motivation Model was a measure for drinking motives in adolescents (Cooper, 1992).

Cooper’s measure was revised a couple years later identifying a fourth motive, but testing
these questionnaires served to bring validity to the conceptual model (Cooper, 1994). The

four drinking motives include: 1) social- to bond with others or facilitate social

interactions, 2) coping- to avoid or escape distressing or negative emotions, 3)
enhancement- to enhance physical or emotional pleasure or create excitement, and 4)
conformity- to gain social approval or avoid disapproval. Validation of the four-motive

structure of the Drinking Motives Questionnaire (DMQ) was later replicated in a Swiss

sample of adolescents (Kuntche et al., 2006). With the DMQ eventually becoming the
gold-standard for substance use motives questionnaires, the basic factor structure was

extended to and modified for substances other than alcohol. These questionnaires include
the Marijuana Motives Measure (MMM), which added an ‘expansion’ motive, the Opioid
Prescription Medication Motives Questionnaire (OPMMQ), and the Opioid Motives

Scale (OMS) (Simons et al., 1998; Jones et al., 2014). These measures of opioid use
motives follow a similar factor structure to what Cooper initially identified; however, the
conformity motive of the DMQ is supplanted by the motivation to use to relieve pain as
pain management is a more frequently cited motive in opioid use (Barth et al., 2013).

Motivations for substance use has received increasing attention as potential

intervening variables between ER deficits and substance use-related outcomes;
enhancement and coping motives have received particular attention due to their ER
regulatory roles. Most work on the relationship between substance use-related motives

come from the alcohol (Aurora & Klanecky, 2015; Messman-Moore & Ward, 2014;

9

Paulus et al., 2021; Simons et al, 2017; Veilleux et al., 2014) and marijuana use
literatures (Bonn-Miller, Vujanovic, Boden, & Gross, 2011; Bonn-Miller, Vujanovic, &

Zvolensky, 2008; Buckner et al., 2017). For instance, one study showed robust
associations between ED and coping motives within a methadone-maintenance sample
(Gold et al., 2020). In support, similar links have been observed among young adult

marijuana smokers (Bonn-Miller et al., 2008). Indeed, ER difficulties were shown to

mediate the relationship between PTSD symptoms and using marijuana to cope; those

with elevated PTSD symptoms evidenced ineffective ER skills, that, in turn, predicted

their reliance on marijuana to manage distress (Bonn-Miller et al., 2011). Similar
mediating role of ER deficits were observed between anxiety and marijuana use within a
treatment sample (Buckner et al., 2017), and between ED and problematic marijuana and

alcohol use within a college sample (Lucke et al., 2021).
Of the various motives that drive opioid use, the literature suggests analysis of

coping motives may hold particular value in identifying and treating problematic using
patterns (Vest & Tragesser, 2019; Menon & Kandasamy, 2018; Baker et al., 2004).

Coping motivated intoxication is itself a maladaptive means of regulating emotions,
which has been linked to other problems in regulating emotion. As ER deficits are

considered a risk factor for opioid use and relapse, coping motives are also emerging to
play a similar role (Paulus et al., 2021; Buckner et al., 2017).

1.5 Coping Motives in Opioid Use & Craving
Craving reduction is a target for opioid treatment, it is therefore of interest
whether coping motives also predict cravings in addition to problematic substance use.

However, only two studies to this author’s knowledge have examined the role of coping
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motives and craving, with mixed results. In their study of opioid misusers in residential

treatment, Scamaldo and colleagues showed that coping motives predicted opioid
cravings independent of other substance-related motives and psychopathology
(Scamaldo, Tull, & Gratz, 2021). However, these results were not replicated in a

laboratory study; opioid user’s coping motives did not significantly predict drug craving
in response to negative affect inductions (Stathopoulou, Pollack, & Otto, 2018).

While few studies have specifically examined coping motives in relation to
negative affect in an opioid sample, there is evidence that coping motives are frequently

endorsed in response to negative affect in relation to other substances (Kuntsche et al.,
2005; Labhart, Kuntsche, Wicki, & Gmel, 2017; Anderson, Briggs, & White, 2013; Read,
Wood, Kahler, Maddock, & Palfai, 2003). For instance, coping motives were linked to

alcohol craving among those experimentally induced into a negative mood state (Hogarth
et al., 2018), and outside of the laboratory among college students who reported at least
one heavy drinking episode (Lindgren et al., 2015). Likewise, coping motives mediate the
association between poor distress tolerance and cannabis craving severity (Farris et al.,

2016; Peraza et al., 2019). In the only study to date to examine substance-related coping
motives and substance use, Waddell and colleagues tested the relationships between

affective states, substance-related motives, and negative affect on alcohol craving and use
via EMA (Waddel, Sher, & Piasecki, 2021). Their results showed that participants’

elevations in negative affect at the time of EMA prompt relative to average levels
predicted increased alcohol cravings, and this effect was more prominent among drinkers

with higher dispositional coping motives. This means for regular drinkers, the tendency

to drink to cope exacerbates the effect negative affect has on initiating cravings.
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As ER deficits are linked to substance-related coping motives (Aurora &

Klanecky, 2015; Bonn-Miller, Vujanovic, & Zvolensky, 2008; Gold et al., 2020), and

also magnify the association between negative affect and craving (Childress et al., 1994;
Huhn et al., 2016; Jenkins et al., 2021), it is feasible that some moderation effects of ER

deficits may come by indirectly via substance-related coping motives. This possibility is
well-aligned with the Self-Medication Hypothesis, which substance use as a coping

response to difficult emotions (Khantzian, 1985), and a reliance on such a response is

likely due to broader ER deficits. Further, this possible relationship would help explain
why emotion regulation skills training reduces cravings, and its empirical examination
may provide insight into novel opioid treatment approaches (Choopan et al., 2016;
Garland & Howard, 2013).

1.6 Measurement of Dynamic Constructs
Research on substance abuse treatment (and most psychological research in

general) has long relied on questionnaires to measure constructs. However, one limitation
of this design is that sampling is cross-sectional, meaning constructs are only measured
once at single point in time. Yet, many psychological constructs, particularly those

related to emotions, are known to fluctuate over time. It is only in the last couple decades
that this methodological issue has been addressed. To improve our measurement and

accuracy of scientific findings, experience sampling has increasingly been integrated into

research designs. Measurement methods such as EMA (i.e. electronic diaries) have
served to both increase ecological validity as well as move past the constraints of crosssectional designs by incorporating repeated measures.
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At present, these limitations remain to a degree in the literature regarding negative
affect and craving. The studies utilizing mood inductions often cite a lack of ecological

validity in their limitations as laboratory settings may not elicit the same responses that
are observed in naturalistic settings. Correlational research often measures negative affect

and craving via self-report questionnaires (ie. PANAS, Penn Alcohol Craving Scale,

Obsessive Compulsive Drinking Scale, Substance Craving Questionnaire). One inherent
flaw in this measurement method is recall bias as responses could be affected by poor

memory and cognitive distortions that occur in the interim period between the event in
question and its assessment (Hammersley, 1994; Sayette, 2000). Real-time assessments
may reduce the effects of recall bias. Lastly, questionnaires measuring craving and

negative affect are essentially treating these constructs as stable factors as is implied by
the use of cross-sectional sampling. As a body of work suggests negative affect and
craving are dynamic constructs, we are tasked with how to correctly interpret such

findings from questionnaires (Shiffman, 2009; Drummond et al., 2000).
Saul Shiffman’s use of real-time assessments has demonstrated the dynamic

nature of craving, showing momentary ratings to vacillate over the course of a day
(Shiffman et al., 1996). He went on to author an article proposing the suitability of EMA
in substance use research (Shiffman, 2009). The main argument behind the suitability of

EMA is that substance use is episodic and believed to be related to mood and context,
which EMA captures well. As repeated measure designs have the capacity to detect

fluctuations in craving and affect over the course of the day, repeated EMAs additionally
examine participants in naturalistic settings, yielding high ecological validity. Lastly,
utilizing repeated measures to index dynamic constructs such as negative affect and
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craving over time allows researchers to address within-subject variability (in addition to

between-subjects variability, which is measured cross-sectionally). This study sought to
refine the measurement of negative affect and craving by incorporating EMA so that the

effects of negative affect on craving while influenced by other study variables could be

analyzed both between and within participants.
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CHAPTER II

CURRENT STUDY AIMS

The present study sought to identify underlying processes along the pathway to
relapse for those in treatment for opioid problems. Elucidation of these factors may

enable clinicians to reduce client cravings, therefore mitigating the risk of lapses during
treatment. As negative affect is known to initiate cravings, ER skills are likely at play as

regulatory deficits may produce negative affect. Deficits in ER were expected to
moderate the association between negative affect and opioid craving. As the research on

ER has not yet clarified the roles repertoire make-up plays in promoting cravings, this

study should grant that clarity by testing both putatively adaptive and maladaptive ER
repertoires in moderator roles. Further, coping motives in substance use have received

increasing attention as a potential mediator between ER deficits and risk for recurrent use
with only one study sampling opioid-dependent users. As coping motives are endorsed in
response to negative affect and predict craving and lapses, coping motives were also

expected to moderate the association between negative affect and craving although no
study had yet tested coping motives in this role in opioid use. While serving to elucidate
the form ER deficits take, whether these be robust maladaptive or limited adaptive
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repertoires, this study aimed to test the conditional effects of coping motives as
mechanistic of the conditional effects of ER deficits.
In addition to these gaps in the literature the project addressed, the
methodological approaches employed also improve our understanding of the

relationships being tested. Given the limitations of questionnaires, EMA has been

recommended in the context of substance use research. This study followed that

recommendation, improving the ecological validity of negative affect and craving ratings.

Incorporating a repeated measures design via EMA to index these dynamic constructs

also enabled the detection fluctuations, improving the precision of effect estimates.
Negative affect and craving were indexed at a state level, varying over time, whereas

opioid use motives and ER were measured at a trait level, invariant over time.

In all, the effects of coping motives and indirect effects of ER were

simultaneously tested as enhancers of contemporaneous drug craving and negative affect
in daily life. As craving is a reliable marker of relapse and early treatment termination,

identifying the roles of craving precipitants amongst themselves begins to elucidate the
processes that govern craving. Analytically, this study allowed the effect of negative
affect on craving and craving baselines to vary from person to person, with cross-level

interactions used to potentially explain this variability. An understanding of how

individual differences in tendencies and skillsets impact lapse risk holds clinical value.
Findings may help clinicians identify OUD clients at higher lapse risk and serve to guide
ER skills training with the aim of reducing cravings, highlighting the importance of ER

based therapies during the early stages of opioid-dependence treatment.
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2.1 Hypotheses
Hypothesis 1. High reliance on maladaptive emotion regulation strategies and infrequent

use of adaptive emotion regulation strategies will significantly predict tendencies to use

opioids to cope.
Hypothesis 2a. Tendencies to use opioids to cope will exacerbate the person varying

relationship between negative affect and craving in daily life across the course of a week.
Hypothesis 2b. Tendencies to use opioid to cope will exacerbate the relationship between

the time-invariant components of negative affect and craving in daily life.
Hypothesis 3a. Infrequent use of adaptive emotion regulation strategies will indirectly

exacerbate the person varying relationship between negative affect and craving in daily
life across the course of a week through coping motivated opioid use.
Hypothesis 3b. High reliance on maladaptive emotion regulation strategies will indirectly

exacerbate the person varying relationship between negative affect and craving in daily
life across the course of a week through coping motivated opioid use.
Hypothesis 4a. Infrequent use of adaptive emotion regulation strategies will indirectly

exacerbate the relationship between the time-invariant components of negative affect and
craving in daily life through coping motivated opioid use.

Hypothesis 4b. High reliance on maladaptive emotion regulation strategies will indirectly

exacerbate the relationship between the time-invariant components of negative affect and
craving in daily life through coping motivated opioid use.
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CHAPTER III
METHOD

3.1 Participants
The sample was comprised of fifty-seven adult participants self-identifying as
seeking rehabilitation from opioid dependency by means of mutual help group
involvement. The sample was 42% female (n=24) relative to males with ages ranging from

18 years to 63 years, at an average age of 34.76 years old. Eligibility was defined as within
ninety days of the most recent sobriety lapse and having regular access to a smart cellular

phone.

3.2 Recruitment
Participants were recruited via advertisements posted in major cities across the
nation on Craigslist.com. Those who express interest were contacted via telephone and

screened to assess their merits regarding inclusion criteria. Participants were
compensated up to $25 for their time, disaggregating to $10 for completing the one-hour
battery of questionnaires and $15 for completing at least 80% of EMA surveys (28/35).
Those who completed less than 80% of EMA surveys were still compensated $5 for their

effort in completing the EMA protocol. Nightly emails were sent updating participants on

18

their EMA survey completion percentage progress. Payments were made by either money
order or electronic transfer via PayPal, Cash App, and Venmo.

3.3 Measures
3.3.1 General measures.
Demographic questionnaire. An 11-item measure collecting personal information
including age, gender, education level, race, country of origin, number of years and

generations family has been in the U.S., sexual orientation, gender orientation, number of
days sober, and mutual help group program affiliation.

Opioid motives scale (OMS). The opioid motives scale is a 27-item self-report
questionnaire used to assess participants’ rationale for using opioids. Each item

corresponds with one of four motives for using opioids: enhancement, coping, social, and
pain. Participants endorse items based on the frequency they’ve used for the

corresponding reason. Items are assessed on a 6-point scale: Never (0), Very Rarely (1),

Rarely (2), Occasionally (3), Frequently (4), and Very Frequently (5). This measure is a
product of motivational theory, from which the Drinking Motives Questionnaire is
derived (Cox & Klinger, 1988; Cooper, 1994). Multiple scales have been adapted to

assess using motives in substances other than alcohol. The OMS is a version of the
validated Opioid Prescription Medication Motives Questionnaire (OPMMQ), which

identified a four-factor model for the primary reasons opioids are used (Jones et al.,

2014). To develop the OMS, the OPMMQ was adapted to include non-prescription
opioid use by simply removing the item “How often have you used opioids... because it

is safer than street drugs.” The OPMMQ demonstrated excellent internal consistency in
the enhancement (a = 0.96), coping (a = 0.93), social (a = 0.92), and pain (a = 0.91)
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subscales (Jones et al., 2014). Akin to the OPMMQ, items of the OMS are aggregated
into four distinct scales reflecting the same cardinal motives to use opioids. In this

sample, the OMS demonstrated acceptable reliability in the enhancement (a = 0.84),

coping (a = 0.81), social (a = 0.93), and pain (a = 0.78) subscales.

Feelings and me- adult version (FAM-A). The FAM-Adult is a 56-item self
report questionnaire measuring dispositional tendencies to deploy emotion regulation

strategies in response to sadness across cognitive (e.g., re-evaluation), behavioral (e.g.,
planned action), and interpersonal (e.g., engaging with other to relieve one’s distress)

domains. Each item begins with “When I feel sad or down, I...” followed by either an

adaptive response (e.g., “I try to find something constructive to do”) or a maladaptive
emotion regulation response (e.g., “I think about how badly I feel; I use drugs”).
Participants respond on a 3-point scale for each item: Not true of me (0), Sometimes true

of me (1), or Many times true of me (2). In creating this questionnaire, a panel of judges

consisting of seven clinical psychologist researchers classified each item as either an
adaptive or maladaptive emotion regulation response, requiring agreement by at least five
out of seven judges. In respect to scoring, 32 of these items are classified as adaptive,

while 24 are classified as maladaptive. This measure can be broken into two subscales: a

subtotal score of the items reflecting putatively maladaptive ER repertoires and another
subtotal reflecting putatively adaptive ER repertoires. The FAM-A maladaptive and

adaptive subscales have been shown to demonstrate good psychometric properties in the
form of high internal consistency among healthy individuals (a = 0.80 & a = 0.89,

respectively) and those with a history of depression (a = 0.91 & a = 0.88, respectively)
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(Kovacs, Rottenberg, & George, 2009). In this sample, the FAM-A demonstrated good

reliability in its maladaptive ER (a = 0.90) and adaptive ER (a = 0.93) subscales.

3.3.2 Ecological momentary assessment measures.

Negative affect. Negative affect was measured at both moments of peak distress
(“Rate how you were feeling when you felt the worst/ most negative...” or “Rate how
you were feeling right before you used...”) since responding to their most recent EMA
prompt and current moments (“Rate how you feel at this moment...”) while responding

to the survey. An index score was aggregated with items taken from the Positive and
Negative Affect Schedule, reflecting feeling sad, angry, upset, frustrated, and stressed

(Watson et al., 1988). Each of the five items was assessed on a 5-point Likert scale: very

slightly/ not at all (1), a little (2), moderately (3), quite a bit (4), and extremely (5).

Craving. Craving was measured at both moments of peak distress (“How strongly
did you crave substances when you felt the worst/ most negative?” or “How strongly did

you crave substances before you used?”) since responding to their most recent EMA
prompt and current moments (“How strongly do you crave substances at this moment?”)

while responding to the survey. Craving was assessed on a slider scale of 0-100: not at all

(0) and extremely (100).

3.4 Procedures
3.4.1 Online questionnaires.
The study was earned out remotely by means of telephone and email. An initial
telephone call served as an orientation to the study. Eligible participants were given an
identification number and emailed a website link containing the informed consent

document followed by online questionnaires. Upon consenting to participate following
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the phone call, participants privately completed a battery of online questionnaires (~60

minutes). This battery included measures of demographic characteristics, emotion

regulation (FAM-A), and motives for opioid use (OMS).

3.4.2 Ecological momentary assessment.
Upon completion of the online questionnaires, EMA sampling was conducted for a
period of 7-consecutive days, commencing the following morning. Brief (~3 minute)
surveys were sent to participants’ cell phones via text message or email operating through

SurveyHub (Ghose, 2017). Prompts were fixed for random delivery five times each day

(spaced at least 2 hours apart) between the hours of 6am and 10pm, although
accommodations were made to fit participants’ schedules in order to encourage higher
response rates. Participants were given a 30-minute window to complete each survey

before the link became inactive. In accordance with best practices (Shiffman, Stone, &
Hufford, 2008), participants were sent a reminder prompt 15 minutes after receiving the

initial prompt.

3.5 Analytic Approach
SPSS v. 28 was used to examine descriptive statistics and bivariate correlations

among study variables. Regression assumptions were then examined including normality,
linearity, homoscedasticity, independence of errors, and multicollinearity. Multivariate
multiple regression was conducted using the multivariate general linear model command

in SPSS v. 28. Multilevel regression was employed via the mixed model command in the
same version of SPSS. Fitting a multilevel model accounted for nesting in the EMA data,
a violation of the independence of errors assumption in single-level regression. This

study aimed to assess mediation following the joint significance approach (see figure 1).
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Path ‘a’ would have regressed coping motives onto adaptive and maladaptive ER

repertoires via OLS multiple regression. Path ‘b’ would have tested same-level and cross

level interactions between coping motives and negative affect in predicting craving.
Simple slopes would have then been plotted to graphically determine the nature of
interactions. Path ‘a’ and each simple slope in path ‘b’ would have then been used to

calculate indirect effects by the Monte Carlo Method for Assessing Mediation, a
bootstrapping method estimated with 5,000 samples at bias-corrected 95% confidence

intervals (Selig & Preacher, 2008). Unfortunately, recruitment fell below the stated goals,
reducing statistical power. As a result, there was not enough statistical power to detect the

indirect effects that would have tested hypotheses 3a - 4b. Instead, in a piecemeal
approach, both coping motives alone and with the other three opioid use motives were

each regressed onto adaptive and maladaptive ER repertoires in multiple regression and
multivariate multiple regression, respectively. Then, coping motives were examined as a

moderator of negative affect and craving in same- (level 2 x level 2) and cross-level
(level 2 x level 1) interactions in a multilevel model, including first-order effects in the

model. Lastly, the piecemeal approach included examining the moderating effects of

adaptive and maladaptive ER repertoires on negative affect and craving in consideration
of the total effect (path ‘c’) in the proposed mediation model. Per best practices, negative
affect (collected via EMA) was disaggregated into its time-varying (level 1) and time

invariant (level 2) in all multilevel analyses (see Enders & Tofighi, 2007). To index time
invariant negative affect, negative affect ratings for the week were aggregated to an

average rating for each participant. In all multilevel analyses, the effect of negative affect
on craving was free to vary (random slope) as guided by indices in the model building
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process. Level 2 predictors were grand mean centered and level 1 predictors were group

mean centered (Enders & Tofighi, 2007). The effects of participants’ age and sex were

controlled for in all models.

3.5.1 Power analysis.
A priori power analyses were conducted to identify the required sample size for

detecting the hypothesized effects. As path ‘a’ examines constructs on the same level
(level 2), G*Power (Faul & Erdfelder, 1992) is a sufficient tool for calculating the

statistical power of this path. At an alpha level of .05 (two-tailed), and a moderate effect
size (f2=. 15; Cohen, 1988) for three variables (coping motives, adaptive ER repertoires,
maladaptive ER repertoires), 55 participants would be required to achieve statistical

power of .80. Path ‘b’ sought to examine relationships among variables at multiple levels,

therefore, calculation of statistical power required software for multilevel analysis;
Optimal Design (Raudenbush et al., 2011) was utilized for this task. In calculating
required sample size for the interaction at level 2 between coping motives and time

invariant negative affect in predicting craving, including first-order effects (path ‘b’), 83
participants were required when the alpha level was set at .05, the effect size was

moderate (d=.5; Cohen, 1988), and the ICC was .593 to achieve statistical power of .80.

The sample size for a cross-level interaction between coping motives and time-varying
negative affect in predicting craving, including first-order effects (path ‘b’) required 12
participants with the alpha level set at .05, the effect size moderate (d=.5; Cohen, 1988),

and level 1 variance at .20 (since the slope of negative affect was random) to achieve

power of .80. These multilevel power calculations were based on cluster sizes of 49

observations per participant; previous study records have guided this estimation as
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individuals of this population completed ~ 70% of EMA surveys. Recruitment of 83
participants would have rendered the ability to detect effects across levels, however, only
57 participants were recruited.
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CHAPTER IV
RESULTS

4.1 Descriptive Analyses
Bivariate correlations among all study variables were examined using Pearson
correlation (see Table 1). Gender was not significantly correlated with other study

variables, and age evidenced a non-significant trend correlation with negative affect and
pain management motives in opioid use (rs=-.17-.21,/w=.068-.087). Though not

associated with variables of interest, gender and age were both included as covariates in
all final analyses based on prior work (Back et al., 2011; Moran et al., 2018). Craving

was highly correlated with negative affect and maladaptive ER, and moderately

correlated with coping motives in opioid use (rs=.27-.48,ps=<001-.03). Craving also
weakly correlated at a trend level with pain management motives in opioid use at a trend

level (r=.22, p=.088). Average EMA-based negative affect was also highly correlated
with maladaptive ER (r=.49, p<.001). Lastly, maladaptive ER also correlated with
enhancement, pain, and coping motives in opioid use but not social motives (rs=.27-.33,

ps=.008-.03) and adaptive ER did not correlate with any opioid use motives.
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4.2 Hypothesis Testing
4.2.1 Hl. High reliance on maladaptive emotion regulation strategies and
infrequent use of adaptive emotion regulation strategies will significantly predict

tendencies to use opioids to cope.
To support other investigations into opioid use motives and emotion regulation, a

preliminary analysis was run to consider the effects of ER strategies on each of the four
opioid use motives, while controlling for demographic characteristics. Coping,
enhancement, pain, and social motives for opioid use (OMS) were simultaneously

regressed onto maladaptive and adaptive ER repertoires (FAM-A) in multivariate
multiple regression.

Independent of the effects of adaptive ER and demographic characteristics,
maladaptive ER significantly predicted coping (b=.12, p=.013), enhancement (b=.14,

p=.042), and pain (¿=.20, p=.009), but not social motives for using opioids (¿=.10,
¿>=.187). Independent of the effects maladaptive ER and demographic characteristics (see
Table 2), adaptive ER failed to predict any of the four opioid use motives (coping ¿=.01,

¿>=.887; enhancement ¿=.00, ¿>=.997; pain ¿=-.02, ¿>=.782; social ¿=.01, p=.878). A posthoc analysis was performed to evaluate whether the three significant effects of
maladaptive ER on the three motive variables (coping, enhancement, and pain) are

comparable in magnitude or significantly differ from one another. Results indicated these
magnitudes (maladaptive ER on coping, enhancement, and pain motives) do not
significantly differ from each other (Wald Chi Square (2) = 2.13,¿>=.344).

The broader model (see Figure 1) sought to test the conditional indirect effects of

adaptive and maladaptive ER repertoires with negative affect on craving via the
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conditional effects of coping motives with negative affect using a series of regression
analyses. This analysis would have constituted path a of the overall model; however, the

indirect effects could not be tested due to a small sample size (underpowered).

4.2.2 H2a. Tendencies to use opioids to cope will exacerbate the person
varying relationship between negative affect and craving in daily life across the
course of a week.
To test hypotheses 2a and 2b, a multilevel model was fit to examine the

moderating effect of trait level coping motives (OMS) on state level negative affect and
craving in participants’ daily lives (ascertained via EMA). The model included age,

gender, coping motives (all level 2), negative affect (at both level 2 and level 1), and the
same- (level 2 x level 2) and cross-level (level 2 x level 1) interaction between and

coping motives and negative affect as predictors of craving (level 1 dependent variable).
Negative affect (collected via EMA) was disaggregated into its time-varying (deviation

around each participant’s average affect rating- level 1) and time-invariant components
(average affect rating per participant- level 2). Due to nesting within subjects, the

intercept (participants’ baseline craving rating) was free to vary across participants as per
the variance partitioning coefficient (ICC= .593). The effect (slope) of negative affect (at

level 1) on craving (level 1) was also set as random in the final analysis, per fit indices
while building the model. The initial plan to test hypothesis 2 involved including the

first-order and moderating effects of both ER deficits and coping motives to control for
the effects of ER deficits in assessing mediation. However, given the small sample, the
effects of adaptive and maladaptive ER repertoires (FAM-A- level 2), as well as each’s
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same- and cross-level interaction effects with negative affect (at both levels) were
unloaded from the model to avoid potential type II error.

As expected, participants’ average negative affect (b=2.93,p<.001) as well as the
deviation around that average (b=1.34,p<.00Insignificantly predicted craving. The first-

order effects of coping motives also accounted for a significant amount of the variance in
craving (¿=1.66, p=.047). The cross-level interaction between coping motives (level 2)

and time-varying negative affect (level 1) predicting craving tested this hypothesis. In

line with expectations, this interaction significantly predicted craving in daily life when
the effect of negative affect on craving was random (b=12,p=.045), independent of the
effects of demographic characteristics and the first-order effects of coping motives and

negative affect (at both levels) (see Table 3). The interaction was then probed graphically

to examine the simple effects of negative affect on craving in those who tended to use
opioids to cope and those who tended to not use opioids to cope (see Figure 2). Graphical

interpretations suggested those who tended not to use opioids to cope experienced a
lower baseline of cravings, although cravings increased as negative affect increased.

(¿=.89, p=.008). Those who did tend to use opioids to cope experienced higher baseline

of cravings and the effect negative affect had on cravings increased (b=1.78, p<.001).

The tendency to use opioids to cope exacerbated the relationship between negative affect
and craving in daily life.

4.2.3 H2b. Tendencies to use opioid to cope will exacerbate the relationship
between the time-invariant component of negative affect and craving in daily life.
The same random intercept-random slope model that tested the previous
hypothesis was used to also test the present hypothesis. The interaction between coping
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motives (level 2) and time-invariant negative affect (level 2) in predicting craving tested
this hypothesis. Contrary to expectations, this interaction did not significantly predict

craving in daily life (b=.22, p=.320), independent of the effects of demographic

characteristics and the first-order effects of coping motives and negative affect (at both
levels) (see Table 3). Because the interaction was not significant at level 2, the simple

slopes were not explored graphically as they would not be interpretable.

4.2.4

Hypothesis 3a - Hypothesis 4b

Hypotheses 3 and 4 considered the indirect moderating effect of ER repertoires on
negative affect predicting craving via the moderating effect of coping motives. Since

there was not enough statistical power to detect the conditional indirect effects of ER
repertoires, hypotheses 3a - 4b were not tested (avoiding potential type II error).

However, exploratory analyses were still conducted to test the total effect (path c) of the
proposed mediation model by examining the moderating effects of ER repertoires on

negative affect and craving (excluding the effects of coping motives). A multilevel model
was fit to examine the same- and cross-level interactions between adaptive ER repertoires

and negative affect as well as maladaptive ER repertoires and negative affect in
predicting craving. This model included age, gender, adaptive and maladaptive ER

repertoires (all level 2), time-varying (level 1) and time-invariant negative affect (level

2), and the same- (level 2 x level 2) and cross-level (level 2 x level 1) interactions
between adaptive ER repertoires and negative affect and maladaptive ER repertoires and

negative affect as predictors of craving (level 1 dependent variable). The intercept was

free to vary across participants as well as the slope of negative affect at level 1.
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In line with expectations, participants’ average negative affect (b=1.66,p=.006)

as well as the deviation around that average (b=1.25, p<.001) significantly predicted

craving. However, the first-order effects of adaptive ER repertoires did not account for a
significant amount of the variance in craving (¿=.19, p =.257). The interaction between

adaptive ER and time-invariant negative affect at level 2 significantly predicted craving
in daily life (b=.12, p =.005), however, the cross-level interaction between adaptive ER
(level 2) and time-varying negative affect (level 1) did not significantly predict craving

(¿=-.02,/?=. 181), independent of the effects of demographic characteristics and first-

order effects of ER repertoires and negative affect (at both levels) (see Table 4). The

significant interaction at level 2 was then probed graphically to examine the simple
effects of negative affect on craving in those with robust adaptive ER repertoires and

those with a dearth of adaptive strategies in their ER repertoires (see Figure 3). Graphical
interpretations suggested in those with robust adaptive repertoires, the effect negative
affect had on cravings was relatively stronger (b=3.19,/?<.001). Those who lacked

adaptive strategies in their repertoire experienced a higher baseline of cravings, although
the effect negative affect had on cravings was much weaker (¿=.13,/?=.648).

The same model that tested the effects of adaptive ER was used to test the effects
of maladaptive ER. The first-order effects of maladaptive ER repertoires accounted for a

significant amount of the variance in craving (¿=.85,/?<001). The interaction between
maladaptive ER and time-invariant negative affect at level 2 did not significantly predict
craving in daily life (b=.04, p =.468), however, the cross-level interaction between

maladaptive ER (level 2) and time-varying negative affect (level 1) did predict craving at
a trend level (¿=.03, p =.062), independent of the effects of demographic characteristics
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and first-order effects of ER repertoires and negative affect (at both levels) (see Table 4).

The trend level cross-level interaction was then probed graphically to examine the simple
effects of negative affect on craving in those with robust maladaptive ER repertoires and

those with few maladaptive strategies in their ER repertoires (see Figure 4). Graphical
interpretations suggested those with few maladaptive strategies in their repertoires

experienced a weaker baseline of cravings, although cravings increased as negative affect

increased (b=.95,p<001). Those with robust maladaptive repertoires experienced
stronger cravings and the effect of negative affect on craving was stronger relative to

those with smaller maladaptive repertoires (b=1,55, p <.001). Having ER repertoires
robust with maladaptive strategies exacerbated the relationship between negative affect

and craving in daily life.
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CHAPTER V

DISCUSSION

The present study aimed to elucidate key underlying processes that lead to opioid
lapse in naturalistic conditions. An ecologically valid understanding of such factors may

be informative to the treatment of OUD. Negative affect and craving were of interest given
each is a robust predictor of lapses in opioid users (Preston et al., 2018). ER deficits likely

contribute to opioid cravings in part by exacerbating negative affect, although the form
these deficits take hadn’t yet been investigated (Evenden, 1999; Fox, Bergquist, Hong &
Sinha, 2007; Fox, Hong, Sinha, 2008). Given the preliminary evidence of coping motives

in substance use playing a role similar to ER deficits (Waddel, Sher, & Piasecki, 2021),
this study hoped to explore coping motives as a potential mechanism. Three sets of

hypotheses were developed to examine these relationships via self-report and in daily life,

although the latter hypotheses examining the mechanistic role of coping motives could not

be tested.
The first hypothesis examined the trait-level relationship between coping motives
opioid use and ER deficits, in the form of maladaptive and adaptive repertoires. This

analysis found maladaptive ER repertoires to be significantly linked to coping,
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enhancement, and pain, but not social motives, although adaptive ER repertoires showed

no significant ties to any motives for opioid use. These findings illustrate reasons other
than socializing are why those with ER deficits use opioids. The results also suggest, in
part, that having deficits in ER is predictive of using opioids to cope at a trait level, and

these deficits take the form of repertoires robust with maladaptive strategies and not
repertoires deficient in adaptive options. While the literature is thin on the relation
between substance use motives and types of regulatory strategies, the discrepancy
between adaptive and maladaptive repertoires is consistent with a meta-analytic review

on emotion regulation strategies in substance-related disorders (Aldao, Nolen-Hoeksema,
& Schweizer, 2010). The review found medium to large effect sizes for avoidance and

rumination (maladaptive regulatory strategies) with substance use and small effect sizes
for reappraisal and acceptance (adaptive regulatory strategies) with substance use. The

discrepant findings suggest the relation between using motives and ER repertoires may
follow suit in substance dependent populations. With regard to specific motives, results

of maladaptive ER are consistent with prior work. Coping motives have shown robust
associations with ER difficulties in similar cross-sectional research on problematic

opioid, alcohol, and marijuana use (Gold et al., 2020; Messman-Moore & Ward, 2014;

Bonn-Miller, Vujanovic, & Zvolensky, 2008). Enhancement motives have also been
connected to ER difficulties in the literature on problematic alcohol use (Aurora &

Klanecky, 2015). To the author’s knowledge, only the link to pain motives is new to the
literature on ER in SUDs, although few studies to date have explored motives in opioid
use, which the pain motive is distinctive. No studies have found a significant association
between social motives in substance use and ER problems. As coping motives in opioid

34

use have demonstrated a strong covariance with difficulties in ER (Gold et al., 2020), the
present results suggest the make-up of ER repertoires may be important to consider in

investigating using motives as deficits in adaptive ER were not predictive of using
motives.

The next set of hypotheses examined trait-level coping motives in opioid use as a

moderator of state-level negative affect and craving in daily life. The first hypothesis was
supported, finding a significant cross-level interaction between coping motives (level 2)

and time-vaiying negative affect (level 1) in predicting craving. The first-order effects of

coping motives on craving were consistent with findings from a similarly designed EMA
study (Scamaldo, Tull, & Gratz, 2021), but not an affect induction study (Stathopoulou,
Pollack, & Otto, 2018). Regarding interaction effects, the simple slopes suggested those

who tend to use opioids to cope experience a higher baseline of cravings and the
tendency to use to cope exacerbates the already strong tie between negative affect and

craving. In examining the second hypothesis, a significant interaction at level 2 was not
found between subject’s average negative affect and tendencies to use opioids to cope in
predicting craving. To the author’s knowledge, no other studies have tested this

interaction in an opioid-dependent sample. However, these results are consistent with an

EMA study on problem drinking, which revealed within-subject elevated negative affect
predicted increased alcohol cravings, and this effect was more prominent among drinkers

who tended to drink to cope (Waddel, Sher, & Piasecki, 2021). In the present study, the

slope of negative affect on craving was random, meaning the relationship between
negative affect and craving was allowed to vary from subject to subject. The results
suggest individual differences in tendencies to use opioids to cope or not helps explain
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the variability in the exacerbating effects of negative affect on craving, although when

disregarding within-subjects variability, coping motives no longer demonstrate these
moderating effects

The final two sets of hypotheses sought to examine coping motives as mechanistic
of ER deficits’ (adaptive and maladaptive repertoires) moderating effect on negative
affect and craving. Unfortunately, recruitment fell below the stated goals and there was

not sufficient statistical power to calculate the indirect effects hypotheses 3a-4b posited.
Instead, the total effect (path c) in the proposed mediation model (excluding the effects of

coping motives) was analyzed. Regarding adaptive ER repertoires, results indicated weak
first-order effects and a significant interaction at level 2, but a non-significant cross-level
interaction. While there is some evidence adaptive ER is deployed relatively infrequently

by opioid users (Hyman et al., 2009), work by Aldao and Nolen-Hoeksema may shed
more light on the findings concerning adaptive ER (2012). The weak first-order effect of

adaptive ER on craving is generally in line with their meta-analysis of ER strategies
across psychopathology, finding adaptive strategies (acceptance and appraisal) to

demonstrate low predictive power in problematic substance use (Aldao, Nolen-

Hoeksema, & Schweizer, 2010). In later work, the effectiveness of adaptive ER responses
has been shown to be contextual as evidenced by adaptive strategies being implemented
with more variability across situations than maladaptive strategies (Aldao & Nolen-

Hoeksema, 2012). Flexibility is necessary in adaptive ER as strategies must be
implemented that are appropriate to varying circumstances and facilitate specific goals
(Aldao, Sheppes, & Gross, 2015). For instance, to regulate anger, one might need to
deploy suppression when his goal is to not let others see his anger but may need the
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flexibility to deploy reappraisal when his goal is to forgive someone to maintain long

term relations. When the goal is forgiveness, suppression may do a poorer job than
reappraisal; the flexibility to deploy reappraisal is required to effectively achieve said
goal. To assess ER flexibility and its adaptiveness with consideration to context, EMA is
the recommended methodology (Aldao, Sheppes, & Gross, 2015). As the present study

employed a trait ER measure, it is feasible that the non-significant cross-level interaction
between adaptive ER repertoires and occasion-related NA fluctuations reflects the ER

measure’s inability to take context into account. In a similar vein, the counterintuitive

second-level interaction between adaptive ER and average NA levels may also suggest
that the adaptive nature of a given ER response is determined by context (Aldao &

Nolen-Hoeksema, 2012; Aldao, Sheppes, & Gross, 2015).

Results of the total effect (path c) of maladaptive ER repertoires as a moderator of
negative affect effect and craving revealed a non-significant interaction at level 2 and a
trend level cross-level interaction. Given the lack of statistical power, its plausible a larger

sample size would reveal a significant cross-level interaction. This may be interpreted as
reliance on maladaptive strategies may help explain individual variability in the within-

subjects effect negative affect has on craving, although when disregarding within-subjects
variability, maladaptive repertoires no longer demonstrate moderating effects. Further

analysis (simple slopes) of the cross-level interaction revealed ER repertoires robust with
maladaptive strategies exacerbated the relationship between negative affect and craving in

daily life. Maladaptive ER findings are consistent with some studies on negative emotion
regulation and craving in alcohol and opioid misuse (Jansen et al., 2019; Hudak et al.,

2022) and suggest ER deficits in part constitute heavy reliance on maladaptive strategies,
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regardless of context. Importantly, the present study provides preliminary evidence that

individual differences in reliance on maladaptive ER strategies explain the variability in
the exacerbating effects of negative affect on craving.

Furthermore, given a) the significant path between maladaptive ER and coping
motives, b) the significant interaction between coping motives and negative affect on

craving, and c) the trend-level interaction between maladaptive ER and negative affect on
craving, there is enough preliminary evidence to consider examining the proposed

mediation model in a larger sample.

5.1 Limitations
Interpretation of this study’s findings should consider the several limitations faced.

The most glaring limitation is the inadequate sample size, which can affect generalizability
as well as the statistical power to detect effects. Each statistical path includes many
parameters (covariates, first-order and interaction effects at multiple levels, as well as
random intercepts and slopes) to estimate resulting in a shortage of degrees of freedom in

the full mediation model, which is why indirect effects were not calculated. Another
recruitment concern relates to sampling strategy. Structured clinical interviews were not

given to ensure inclusion criteria was met. Rather, participants were recruited remotely via
online advertisements and screened via telephone conversation. It cannot be guaranteed
that all participants have an OUD diagnosis and were less than 90 days sober at the time

the study began; this study relied on the combination of an honor-system and the judgement

of the screening researcher.
It is also worth noting a weakness in how negative affect was indexed. To measure

negative affect, ratings of feeling sad, angry, upset, frustrated, and stressed were each
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aggregated to a total score reflecting negative affect. More discrete measurement of
negative affect could improve the variable’s potentially weak construct validity. Lastly,

with regard to construct measurement, the scales reflecting opioid use motives offer their

own limitation. Recent work suggests opioid use motives are a dynamic construct, subject

to fluctuations across the course of a day (Votaw & Witkiewitz, 2021). The present study

assessed motives for using opioids as a more static construct reflecting dispositional
tendencies. Lastly, the lack of consideration to the context adaptive ER strategies were

deployed in rendered respective results difficult to interpret.

5.2 Future Directions
Future research in this area should recruit a larger sample to test the entire

mediation model and avoid overfitting such a complex statistical model. It may be difficult
to ascertain precise required sample size estimates for complex statistical models with
currently available power analysis tools. Surpassing recruitment goals would reduce any
uncertainty regarding model fit or effect significance. Next, recruiting from an addiction

treatment center or including an assessment or clinical interview into the screening process

could increase certainty about participants meeting inclusion criteria (diagnosis of OUD).
As this study failed to meet its stated recruitment goals, the proposed mediation

model could not be tested. Future studies are encouraged to test the indirect effects of ER

deficits as a moderator of negative affect and craving through coping motives, particularly
the conditional indirect effects of maladaptive ER repertoires as maladaptive repertoires

explained substantially more of the variance in craving scores. This study has laid the
groundwork by testing all paths relevant to the proposed mediation; however, a larger
sample size would be required to test indirect effects.
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Regarding the measurement of opioid use motives (OMS), future research could

improve on this study by incorporating the construct into an EMA protocol. Indexing
opioid use motives by EMA allows motives to be measured at a state-level as opposed to
a trait-level. As EMA is a repeated measures approach, this enables the researcher to

capture changes in motives to use over time. Future research may find improved results by
indexing adaptive ER via EMA. This would enable the deployment of adaptive ER

strategies to be measured with consideration to varying contexts (Aldao, Sheppes, & Gross,
2015).

Additionally, craving makes an excellent criterion variable, however, craving is not
a perfect predictor of sobriety lapses. If future research would include an additional

variable into an EMA protocol measuring whether a participant lapses or staves off a

craving, more could be elucidated about the roles of all study variables to better inform

current treatments or even new interventions. EMA research on substance use disorders
(especially that which aims to predict lapses) is relevant to the development of new brief

and mobile interventions that use similar devices (i.e. smart phones).
Lastly, the data collected via EMA is self-report. While there is much overall value

in EMA, the subjectivity of self-report is not ideal. Future research in this area is

encouraged to integrate more objective ecological measures alongside an EMA protocol.
For instance, some constructs may be indexed via “wearables” like sensor-laden wristbands

that tap into psychophysiology (i.e. heart rate, stress levels, body temperature, and

emotional responsiveness). Incorporating more objective measurement will improve
validity, helping ground results obtained via EMA.
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5.3 Strengths and Clinical Implications
The strengths of the present study can be seen in its design. Employing a repeated
measures design through EMA enabled fluctuations in key dynamic constructs (negative
affect and craving) to be captured for each participant, measuring these constructs at a state

level. Next, the EMA design also allowed negative affect and craving to be assessed within
a naturalistic setting, improving these constructs’ ecological validity. Further, the use of

real-time (or close to) assessments via EMA also reduces the chance of recall bias
(Hammersley, 1994; Sayette, 2000). By incorporating a psychometric ally sound
questionnaire alongside the EMA protocol, deficits in maladaptive ER could be assessed
reliably at a trait level. Furthermore, the analytic approach (MLM) allowed within-subject

relationships between negative affect and craving to be tested simultaneously alongside

between-subjects relationships.

Of the findings that could be ascertained, demonstrating a relationship between

coping motives and ER deficits serves to bolster the literature in this area, reiterating
others’ work about the clinical relevancy of coping motives in opioid problems, while

also discerning that these deficits take the form of robust maladaptive repertoires and not
small adaptive repertoires although this may be explained by a lack of consideration to

context. Next, the clinical relevancy of coping motives was further signified with finding
that these motives exacerbate the effect of negative affect on craving. These results

suggest the reasons clients tend to use opioids may say much about the cravings they will

experience during distressing situations. Therefore, if a clinician understands clients’
using rationales (ie. coping), he/she may better identify clients at higher lapse risk.
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There may also be clinical value in parsing out the form ER deficits take in

exacerbating the effect of negative affect on craving. While preliminary evidence
suggests reliance on maladaptive strategies is a larger contributor to cravings than lacking

in the use of adaptive strategies, a contextual model of emotion regulation may suggest

deficient adaptive repertoires still promote cravings under various circumstances. More
research is needed to fully understand the role of adaptive repertoires in exacerbating

cravings.
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APPENDIX A: Tables

Table 1. Descriptive statistics and correlations among demographic, opioid use motives,
ER repertoires, negative affect, and craving.
M(SD)
1.

3.
4.
5.
6.
7.
8.
9.
10.

Age
Gender
Enhance
Coping
Pain
Social
AMR
MMR
NA
Craving

34.76(10.96)
—
17.75 (4.55)
14.71 (3.43)
17.76 (5.35)
13.05 (4.92)
58.26(11.95)
44.95 (9.26)
11.24 (4.17)
27.70 (24.29)

1.
—

2.
-.03
—

3.
.08
-.05
—

4.
.11
.02
70***
—

5.
.21
-.07
.48***
52***
—

6.
.02
-.23
72***
.32*
.28*
—

7.
-.09
.04
.03
.08
.02
.01
—

8.
-.04
-.01
.27*
.32**
.33**
.19
-.06
—

9.
-.17
-.12
.08
.11
.21
.09
.06
49***
—

10.
-.09
.04
.19
.27*
.16
.07
46***
.48***
___

***p≤001, **p≤01, *p≤.05
Note. Enhance= OMS enhancement motives subscale total score; Coping= OMS coping
motives subscale total score; Pain= OMS pain motives subscale total score; Social= OMS
social motives subscale total score; AMR= FAM adaptive subscale total score; MMR=
FAM maladaptive subscale total score; NA= participant’s average negative affect rating
via EMA; craving= participant’s average craving rating via EMA.
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Table 2. Univariate effects of multivariate multiple regression predicting opioid use
motives.

Dependent
Variable

Coping
Motives

Enhancement
Motives

Pain
Motives

Social
Motives

Parameters

Intercept
Age
Gender
MMR
AMR
Intercept
Age
Gender
MMR
AMR
Intercept
Age
Gender
MMR
AMR
Intercept
Age
Gender
MMR
AMR

B

7.11*
.05
.20
.12**
.01
9.41*
.07
-.22
.14*
.000
5.08
.14*
.03
.19**
-.02
8.19
.04
-1.96
.10
.01

SE(B)

3.30
.04
.88
.05
.04
4.57
.06
1.22
.07
.05
4.95
.06
1.32
.07
.05
4.89
.06
1.30
.07
.05

t

2.15
1.16
.23
2.58
.14
2.06
1.20
-.19
2.08
.00
1.03
2.28
.02
2.71
-.28
1.68
.57
-1.51
1.34
.16

95% Confidence
Interval
Lower
Upper
Bound
Bound
.492
13.726
-.035
.131
-1.559
1.962
.027
.220
-.067
.077
.247
18.572
-.046
.183
-2.662
2.213
.005
.272
-.099
.100
-4.834
15.002
.017
.265
-2.607
2.670
.050
.339
-.123
.093
-1.608
17.995
-.088
.158
-4.571
.645
-.047
.238
-.098
.115

Note. Gender= 0 = male, 1 = female; Coping Motives= OMS coping motives subscale
total score; Enhancement Motives= OMS enhancement motives subscale total score; Pain
Motives= OMS pain motives subscale total score; Social Motives= OMS social motives
subscale total score; MMR= FAM maladaptive subscale total score; AMR= FAM
adaptive subscale total score.
***p < .001, **p < .01, *p < .05
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Table 3. Fixed effects and variance-covariance estimates for the mixed model interaction
between coping motives (moderator) and negative affect in predicting craving.
Parameters

B

Intercept

31.37***

Age
Gender
MeanNA
Coping
MeanNAxCoping

.20
-.26
2.93***

NA
NAxCoping

1.34***
.12*

Parameters

Intercept
NA
Residual (e)

1.66*
.22

t

SE(B)

2.84

11.06
Level 2
.29
.68
6.02
-.04
.77
3.79
.82
2.03
.22
1.00
Level 1
.21
6.44
.06
2.06

Random Parameters
SE(B)
WaldZ

Variance
Component
464.75
91.08
1.56
.43
318.499
8.93

5.10
3.63
35.66

55.03

95% Confidence
Interval
Lower
Upper
Bound
Bound
25.687
37.061

59.01
55.58
55.33
54.79
54.72

-.389
-12.328
1.378
.020
-.221

.789
11.811
4.477
3.308
.666

50.35
46.77

.920
.003

1.75
.240

df

95% Confidence Interval
Lower Bound Upper Bound
316.518
682.391
.911
2.682
301.466
336.495

Note. Gender= 0 = male, 1 = female; Coping= OMS coping motives subscale total score;
MeanNA= participant’s average negative affect rating via EMA; NA= deviation around
participant’s average negative affect rating via EMA.
***p < .001, **p ≤ .01, *p < .05
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Table 4. Fixed effects and variance-covariance estimates for the mixed model interaction
between ER deficits (moderators) and negative affect in predicting craving.
Parameters

B

Intercept

23.78***

2.21

Age
Gender
MeanNA
AMR
MMR
MeanNAxAMR
MeanNAxMMR

.06
5.74
1.66**
.19
.85***
.12**
.04

.18
3.98
.60
.16
.24
.04
.06

NA
NAxAMR
NAxMMR

1 25***
-.02
.031

.15
.01
.02

Parameters

Intercept
NA
Residual (e)

t

SE(B)

10.74
Level 2
.32
1.44
2.78
1.14
3.53
2.86
.73
Level 1
8.09
-1.35
1.89

Random Parameters
Variance
SE(B)
Wald Z
Component
371.97
55.49
6.70
1.43
.30
4.85
283.971
6.09
46.65

97.60

95% Confidence
Interval
Lower
Upper
Bound
Bound
19.390
28.178

99.36
97.55
101.00
97.36
96.52
99.42
97.17

-.301
-2.16
.478
-.137
.370
.038
-.073

.416
13.63
2.848
.508
1.323
.210
.159

93.07
88.99
86.26

.941
-.043
-.002

1.554
.008
.063

df

95% Confidence Interval
Lower Bound
Upper Bound
277.376
498.010
.957
2.149
272.287
296.158

Note. Gender= 0 = male, 1 = female; AMR= FAM adaptive subscale total score; MMR=
FAM maladaptive subscale total score; MeanNA= participant’s average negative affect
rating via EMA; NA= deviation around participant’s average negative affect rating via
EMA.
***p < .001, **p < .01, *p ≤ .05
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APPENDIX B: Figures

Figure 1. Adaptive ER= FAM adaptive subscale total score; Maladaptive ER= FAM
maladaptive subscale total score; Coping Motives= OMS coping subscale total score;
Mean NA= participant’s average negative affect rating via EMA; NA= deviation around
participant’s average negative affect rating via EMA.
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